| 1 |
Ferrara F, Massari G, Tagliaferri V, Corso G. Prophylactic Total Gastrectomy: How Many? Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_16] [Reference Citation Analysis]
|
| 2 |
Bussa M, Turati F, Bonzi R, La Vecchia C. Family History and the Risk of Breast and Gastric Cancer. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_1] [Reference Citation Analysis]
|
| 3 |
Massari G, Tagliaferri V, Corso G. Worldwide CDH1 Germline Mutation Frequency. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_2] [Reference Citation Analysis]
|
| 4 |
López MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE, Sarmiento M, Pinto JA, Fajardo W. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol 2023;181:103841. [PMID: 36240980 DOI: 10.1016/j.critrevonc.2022.103841] [Reference Citation Analysis]
|
| 5 |
Pereira J, Melo S, Carneiro P, Fernandes MS, Figueiredo J, Seruca R. Revisiting the Biological and Clinical Impact of CDH1 Missense Variants. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_6] [Reference Citation Analysis]
|
| 6 |
Corso G, Magnoni F, Veronesi P. Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer. Ann Surg Oncol. [DOI: 10.1245/s10434-022-12542-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Kohansal M, Ghanbarisad A, Tabrizi R, Daraei A, Kashfi M, Tang H, Song C, Chen Y. tRNA-derived fragments in gastric cancer: Biomarkers and functions. J Cell Mol Med 2022. [PMID: 35957621 DOI: 10.1111/jcmm.17511] [Reference Citation Analysis]
|
| 8 |
Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
|
| 9 |
Corso G, Magnoni F, Trovato C, Girardi A, Seruca R, Figueiredo J, Roviello F. Hereditary Gastric Cancer: A New Syndrome. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_5] [Reference Citation Analysis]
|
| 10 |
Kiseleva A, Zezyulina A, Mikerova M, Bykov I, Reshetov I. Clinical value of CDH1 gene in gastric cancer. Onkol Z im P A Gercena 2022;11:74. [DOI: 10.17116/onkolog20221102174] [Reference Citation Analysis]
|
| 11 |
Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM, Vicini E, Bonanni B, Veronesi P, Galimberti V, Bagnardi V. CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. J Med Genet 2021:jmedgenet-2021-108226. [PMID: 34952833 DOI: 10.1136/jmedgenet-2021-108226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Adib E, El Zarif T, Nassar AH, Akl EW, Abou Alaiwi S, Mouhieddine TH, Esplin ED, Hatchell K, Nielsen SM, Rana HQ, Choueiri TK, Kwiatkowski DJ, Sonpavde G. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 2021. [PMID: 34949788 DOI: 10.1038/s41416-021-01673-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Barbosa-Matos R, Leal Silva R, Garrido L, Aguiar AC, Garcia-Pelaez J, André A, Seixas S, Sousa SP, Ferro L, Vilarinho L, Gullo I, Devezas V, Oliveira R, Fernandes S, Costa SC, Magalhães A, Baptista M, Carneiro F, Pinheiro H, Castedo S, Oliveira C. The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing. Cancers (Basel) 2021;13:4464. [PMID: 34503274 DOI: 10.3390/cancers13174464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Figueiredo J, Mercadillo F, Melo S, Barroso A, Gonçalves M, Díaz-Tasende J, Carneiro P, Robles L, Colina F, Ibarrola C, Perea J, Morais-de-Sá E, Seruca R, Urioste M. Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers (Basel) 2021;13:4359. [PMID: 34503169 DOI: 10.3390/cancers13174359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 16 |
Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 Germline Mutations in Non-Gastric Cancers. Cancers (Basel) 2021;13:2321. [PMID: 34066044 DOI: 10.3390/cancers13102321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
